D-0432-2025 Class II Terminated

Recalled by KENIL HEALTHCARE PRIVATE LIMITED — Ta. Kadi, District Mehsana, N/A

FDA drug recall D-0432-2025 was initiated by KENIL HEALTHCARE PRIVATE LIMITED on Apr 24, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Feb 19, 2026). Affected quantity: 615, 600 Tubes.

Recall details

Product Type
Drugs
Report Date
May 28, 2025
Initiation Date
Apr 24, 2025
Termination Date
Feb 19, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
615, 600 Tubes

Product description

Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, NET WT 0.85 oz (24 g) Tube, Made in India, Dist. by Bob Barker Co. Inc. Fuquay-Varnia, NC 27526, NDC 53247-132-03

Reason for recall

CGMP Deviations

Distribution pattern

DE and NC

Code information

Lot B0008, B0009, B0017, Exp Date: 05/31/2026; Lot B0042, B0043, B0044, Exp Date: 06/30/2026; Lot B0049, B0050, B0051, B0054, B0058, B0059, Exp Date: 07/31/2026; Lot B0061, B0062, B0063, B0064, B0065, B0068, B0069, Exp Date: 08/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0432-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0432-2025. Report a data issue: hello@regdatalab.com.